<DOC>
	<DOCNO>NCT01634165</DOCNO>
	<brief_summary>This study involve 2 single injection LY2963016 2 single injection Lantus . There least 6 day injection . The study compare LY2963016 Lantus two different dos . This study approximately 10 week long , include screen . Screening require within 4 week start study .</brief_summary>
	<brief_title>A Study LY2963016 Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Healthy male female Women must either surgically sterile , postmenopausal , agree use reliable method birth control study Have body mass index 18.5 29.9 kilogram per meter square ( kg/mÂ² ) Are nonsmoker smoke least 6 month prior enter study Have normal blood pressure pulse rate screen , determine investigator Have electrocardiogram ( ECG ) screening consider within normal limit investigator Have clinical laboratory test result within normal reference range population Have fast plasma glucose &lt; 110 milligram per deciliter ( mg/dL ) ( &lt; 6.0 micromoles per liter [ mmol/L ] ) screening Have venous access sufficient allow blood sampling , intravenous drug administration , clamp procedure per protocol Have give write informed consent approve Lilly ethical review board ( ERB ) govern site Are persons previously complete withdrawn study Are currently enrol discontinue within last 30 day clinical trial involve investigational drug device concurrently enrol type medical research judge scientifically medically compatible study Have know allergy insulin , excipients , related drug history relevant allergic reaction origin Have significant history current cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data Show evidence significant active neuropsychiatric disease Show evidence current use know drug abuse history use within past year Have history firstdegree relative know diabetes mellitus Show evidence acute infection fever infectious disease time study entry Show evidence human immunodeficiency virus ( HIV ) infection and/or positive human HIV antibody screen Have positive hepatitis B surface antigens screen Intend use overthecounter medication within 7 day prescription medication within 14 day prior dose ( apart vitamin/mineral supplement , occasional paracetamol , thyroid replacement , birth control method ) Have donate blood blood loss 450 milliliter ( mL ) 3 month prior study enrollment Have average weekly alcohol intake exceed 21 unit per week ( male ) 14 unit per week ( female ) unwilling stop alcohol consumption 48 hour prior dose discharge clinical research unit ( CRU )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>